R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

  1. Sancho, J.-M.
  2. Fernández-Alvarez, R.
  3. Gual-Capllonch, F.
  4. González-García, E.
  5. Grande, C.
  6. Gutiérrez, N.
  7. Peñarrubia, M.-J.
  8. Batlle-López, A.
  9. González-Barca, E.
  10. Guinea, J.-M.
  11. Gimeno, E.
  12. Peñalver, F.-J.
  13. Fuertes, M.
  14. Bastos, M.
  15. Hernández-Rivas, J.-Á.
  16. Moraleda, J.-M.
  17. García, O.
  18. Sorigué, M.
  19. Martin, A.
Revue:
Cancer Medicine

ISSN: 2045-7634

Année de publication: 2021

Volumen: 10

Número: 4

Pages: 1314-1326

Type: Article

DOI: 10.1002/CAM4.3730 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus